Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric ALL: where are we going and how do we get there?. Blood. 2012;120:1165–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeung DTO, Osborn MP, White DL. B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification. British J Haematol. 2022;197:13–27.

Article  CAS  Google Scholar 

Duffield AS, Mullighan CG, Borowitz MJ. International consensus classification of acute lymphoblastic leukemia/lymphoma. Virchows Arch. 2023;482:11–26.

Article  CAS  PubMed  Google Scholar 

Bardelli V, Arniani S, Pierini V, Di Giacomo D, Pierini T, Gorello P, et al. T-Cell ALL: biomarkers and their clinical usefulness. Genes. 2021;12:1118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. J Clin Oncol. 2009;27:4352–6.

Hayette S, Tigaud I, Maguer-Satta V, Bartholin L, Thomas X, Charrin C, et al. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood. 2002;99:4647-9.

Burmeister T, Gokbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S. NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood. 2006;108:3556–9.

Article  CAS  PubMed  Google Scholar 

Tavakoli Shirazi P, Eadie LN, Heatley SL, Hughes TP, Yeung DT, White DL. The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL. British J Cancer. 2020;122:455–64.

Article  Google Scholar 

Truong TH, Jinca C, Mann G, Arghirescu S, Buechner J, Merli P, et al. Allogeneic hematopoietic stem cell transplantation for children with acute lymphoblastic leukemia: shifting indications in the era of immunotherapy. Front Pediatr. 2021;9:782785.

Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera J-M, et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. New Engl J Med. 2017;376:836–47.

Article  CAS  PubMed  Google Scholar 

George P, Dasyam N, Giunti G, Mester B, Bauer E, Andrews B, et al. Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE). BMJ Open. 2020;10:e034629.

Article  PubMed  PubMed Central  Google Scholar 

Dai Y-T, Zhang F, Fang H, Li J-F, Lu G, Jiang L, et al. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. Proceedings Natl Acad Sci. 2022;119:e2120787119.

Article  Google Scholar 

Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage ALL. Nature Genet. 2017;49:1211–8.

Article  CAS  PubMed  Google Scholar 

Müller J, Walter W, Haferlach C, Müller H, Fuhrmann I, Müller M-L, et al. How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia. 2023;37:217–21.

Article  PubMed  Google Scholar 

Pölönen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, et al. The genomic basis of childhood T-lineage acute lymphoblastic leukemia. Nature. 2024;632:1082–91.

Habets RA, de Bock CE, Serneels L, Lodewijckx I, Verbeke D, Nittner D, et al. Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition. Science Transl Med. 2019;11:eaau6246.

Article  CAS  Google Scholar 

Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, Gibbon DG, et al. Phase I Study of RO4929097, a gamma secretase inhibitor of notch signaling, in patients with refractory metastatic or locally advanced solid tumors. Journal Clin Oncol. 2012;30:2348–53.

Article  CAS  Google Scholar 

Diaz-Padilla I, Wilson MK, Clarke BA, Hirte HW, Welch SA, Mackay HJ, et al. A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecologic Oncol. 2015;137:216–22.

Article  CAS  Google Scholar 

Edwards A, Brennan K. Notch Signalling in Breast Development and Cancer. Front Cell Dev Biol. 2021;9:1–24.

Shimony S, Liu Y, Valtis YK, Paolino JD, Place AE, Brunner AM, et al. Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia. Blood Adv. 2023;7:1092–102.

Article  CAS  PubMed  Google Scholar 

Pagliaro L, Chen S-J, Herranz D, Mecucci C, Harrison CJ, Mullighan CG, et al. Acute lymphoblastic leukaemia. Nature Rev Dis Prim. 2024;10:41.

Article  Google Scholar 

Balducci E, Simonin M, Duployez N, Steimlé T, Dourthe M-E, Villarese P, et al. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL. Blood. 2024;144:988–1000.

Article  CAS  PubMed  Google Scholar 

Antar AI, Otrock ZK, Jabbour E, Mohty M, Bazarbachi A. FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions. Leukemia. 2020;34:682–96.

Article  PubMed  Google Scholar 

Szczepański T, van der Velden VHJ, van Dongen JJM. Classification systems for acute and chronic leukaemias. Best Pract Res Clin Haematol. 2003;16:561–82.

Article  PubMed  Google Scholar 

Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain N, Lamb AV, O’Brien S, Ravandi F, Konopleva M, Jabbour E, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127:1863–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inukai T, Kiyokawa N, Campana D, Coustan-Smith E, Kikuchi A, Kobayashi M, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99-15. British J Haematol. 2012;156:358–65.

Article  CAS  Google Scholar 

Ma M, Wang X, Tang J, Xue H, Chen J, Pan C, et al. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia. Frontiers Med. 2012;6:416–20.

Article  Google Scholar 

Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, et al. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine. American J Hematol. 2021;96:589–98.

Article  CAS  Google Scholar 

Burns MA, Place AE, Stevenson KE, Gutiérrez A, Forrest S, Pikman Y, et al. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001. Pediatric Blood Cancer. 2021;68:e28719.

Article  CAS  PubMed  Google Scholar 

Liu X, Zou Y, Zhang L, Chen X, Yang W, Guo Y, et al. Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China. Journal Cancer Res Clin Oncol. 2021;147:2775–88.

Article  CAS  Google Scholar 

Patrick K, Wade R, Goulden N, Mitchell C, Moorman AV, Rowntree C, et al. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. British J Haematol. 2014;166:421–4.

Article  CAS  Google Scholar 

Neumann M, Heesch S, Gökbuget N, Schwartz S, Schlee C, Benlasfer O, et al. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J. 2012;2:e55–e.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bond J, Graux C, Lhermitte L, Lara D, Cluzeau T, Leguay T, et al. Early response–based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. Journal Clin Oncol. 2017;35:2683–91.

Article  CAS